|
WO2020155098A1
|
|
Pharmaceutical composition for treating diabetes, preparation method therefor, and use thereof
|
|
US2020361952A1
|
|
Thienopyridine derivatives containing unsaturated aliphatic olefinic bond, preparation method and use thereof
|
|
CN110128359A
|
|
A kind of crystal and its preparation method and application of 1 inhibitor of uric acid transporter body
|
|
CN109528706A
|
|
A kind of pharmaceutical composition and its preparation method and application for treating diabetes
|
|
CN109384839A
|
|
Glucagon-like peptide-1 analogs and application thereof
|
|
CN107266557A
|
|
A kind of polyethyleneglycol modified glucagon-like peptide 1 analog
|
|
CN108658879A
|
|
A kind of URAT1 inhibitor and its preparation method and application
|
|
CN107540619A
|
|
A kind of preparation method of the inhibitor of uric acid transporter body 1
|
